Literature DB >> 25331267

Psychosocial Syndemics are Additively Associated with Worse ART Adherence in HIV-Infected Individuals.

Aaron J Blashill1, C Andres Bedoya, Kenneth H Mayer, Conall O'Cleirigh, Megan M Pinkston, Jocelyn E Remmert, Matthew J Mimiaga, Steven A Safren.   

Abstract

Adherence to antiretroviral therapy (ART) among HIV-infected individuals is necessary to both individual and public health, and psychosocial problems have independently been associated with poor adherence. To date, studies have not systematically examined the effect of multiple, co-occurring psychosocial problems (i.e., "syndemics") on ART adherence. Participants included 333 HIV-infected individuals who completed a comprehensive baseline evaluation, as part of a clinical trial to evaluate an intervention to treat depression and optimize medication adherence. Participants completed self-report questionnaires, and trained clinicians completed semi-structured diagnostic interviews. ART non-adherence was objectively measured via an electronic pill cap (i.e., MEMS). As individuals reported a greater number of syndemic indicators, their odds of non-adherence increased. Co-occurring psychosocial problems have an additive effect on the risk for poor ART adherence. Future behavioral medicine interventions are needed that address these problems comprehensively, and/or the core mechanisms that they share.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25331267      PMCID: PMC4405426          DOI: 10.1007/s10461-014-0925-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  27 in total

Review 1.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

2.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 3.  Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes.

Authors:  Aaron J Blashill; Nicholas Perry; Steven A Safren
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

4.  Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.

Authors:  Steven A Safren; Conall M O'Cleirigh; Jacqueline R Bullis; Michael W Otto; Michael D Stein; Mark H Pollack
Journal:  J Consult Clin Psychol       Date:  2012-04-30

5.  Mental health and HIV risk in men who have sex with men.

Authors:  Steven A Safren; Sari L Reisner; Amy Herrick; Matthew J Mimiaga; Ronald D Stall
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

6.  Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure.

Authors:  J Leserman; Z Li; D A Drossman; T C Toomey; G Nachman; L Glogau
Journal:  Psychosom Med       Date:  1997 Mar-Apr       Impact factor: 4.312

7.  Promoting the sexual health of MSM in the context of comorbid mental health problems.

Authors:  Steven A Safren; Aaron J Blashill; Conall M O'Cleirigh
Journal:  AIDS Behav       Date:  2011-04

8.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.

Authors:  Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

9.  DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI.

Authors:  P Amorim; Y Lecrubier; E Weiller; T Hergueta; D Sheehan
Journal:  Eur Psychiatry       Date:  1998       Impact factor: 5.361

10.  Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.

Authors:  Jean-Jacques Parienti; Moupali Das-Douglas; Véronique Massari; David Guzman; Steven G Deeks; Renaud Verdon; David R Bangsberg
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more
  60 in total

1.  Substance use, mental illness, and familial conflict non-negotiation among HIV-positive African-Americans: latent class regression and a new syndemic framework.

Authors:  Allysha C Robinson; Amy R Knowlton; Andrea C Gielen; Joseph J Gallo
Journal:  J Behav Med       Date:  2015-08-22

Review 2.  HIV treatment cascade in MSM, people who inject drugs, and sex workers.

Authors:  Kathryn Risher; Kenneth H Mayer; Chris Beyrer
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.283

3.  Cigarette Smoking and Antiretroviral Therapy (ART) Adherence in a Sample of Heavy Drinking HIV-Infected Men Who Have Sex with Men (MSM).

Authors:  Patricia A Cioe; Kristi E Gamarel; David W Pantalone; Peter M Monti; Kenneth H Mayer; Christopher W Kahler
Journal:  AIDS Behav       Date:  2017-07

Review 4.  ART Adherence Among Men Who Have Sex with Men Living with HIV: Key Challenges and Opportunities.

Authors:  Katherine G Quinn; Dexter R Voisin
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

5.  Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.

Authors:  Matthew J Mimiaga; Elizabeth F Closson; David W Pantalone; Steven A Safren; Jennifer A Mitty
Journal:  Psychol Health Med       Date:  2018-09-13       Impact factor: 2.423

6.  Couple Interdependence Impacts Alcohol Use and Adherence to Antiretroviral Therapy in Malawi.

Authors:  Amy A Conroy; Stacey A McKenna; Allison Ruark
Journal:  AIDS Behav       Date:  2019-01

7.  Clinical correlates of depression chronicity among people living with HIV: What is the role of suicidal ideation?

Authors:  Griffin A Tyree; Florin Vaida; Sidney Zisook; William C Mathews; David J Grelotti
Journal:  J Affect Disord       Date:  2019-07-30       Impact factor: 4.839

8.  Engaging, retaining, and providing transdiagnostic integrated cognitive-behavioral therapy and motivational interviewing for underserved people with HIV.

Authors:  Audrey Harkness; Brooke G Rogers; Marc Puccinelli; Ivan Ivardic; Gail Ironson; Steven A Safren
Journal:  Psychotherapy (Chic)       Date:  2019-12-19

Review 9.  Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.

Authors:  Linda-Gail Bekker; George Alleyne; Stefan Baral; Javier Cepeda; Demetre Daskalakis; David Dowdy; Mark Dybul; Serge Eholie; Kene Esom; Geoff Garnett; Anna Grimsrud; James Hakim; Diane Havlir; Michael T Isbell; Leigh Johnson; Adeeba Kamarulzaman; Parastu Kasaie; Michel Kazatchkine; Nduku Kilonzo; Michael Klag; Marina Klein; Sharon R Lewin; Chewe Luo; Keletso Makofane; Natasha K Martin; Kenneth Mayer; Gregorio Millett; Ntobeko Ntusi; Loyce Pace; Carey Pike; Peter Piot; Anton Pozniak; Thomas C Quinn; Jurgen Rockstroh; Jirair Ratevosian; Owen Ryan; Serra Sippel; Bruno Spire; Agnes Soucat; Ann Starrs; Steffanie A Strathdee; Nicholas Thomson; Stefano Vella; Mauro Schechter; Peter Vickerman; Brian Weir; Chris Beyrer
Journal:  Lancet       Date:  2018-07-20       Impact factor: 79.321

10.  Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.

Authors:  Bianca Yeung; N A Mohd Salleh; Eugenia Socías; Huiru Dong; J Shoveller; J S G Montaner; M-J S Milloy
Journal:  AIDS Behav       Date:  2019-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.